Browse studies

Find your next paid study

266 recruiting studies matching your filters

Testicular Tissue Cryopreservation for Fertility Preservation in Patients Facing Infertility-causing Diseases or Treatment Regimens.

The "Testicular Tissue Cryopreservation" study is open to a subset of patients facing disease or treatment regimens that could lead to infertility (gonadotoxic…

Fertility Issues

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT06387498

Phase 1

A First-in-human, Phase 1/2, Multicenter, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of ADCE-D01, a Humanized Anti-human uPARAP Antibody Linked to a Topoisomerase I Inhibitor, in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.

Metastatic Soft Tissue SarcomaUnresectable Soft Tissue Sarcoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Adcendo ApSNCT06797999

Phase 3

A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years w…

Chondral DefectOsteochondritis Dissecans (OCD)Articular Cartilage Defect+1 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Vericel CorporationNCT03588975

Phase 3

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (d…

Plasma Cell MyelomaRISS Stage I Plasma Cell MyelomaRISS Stage II Plasma Cell Myeloma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

ECOG-ACRIN Cancer Research GroupNCT04566328

Prospective Multicenter Trial Evaluating the Efficacy and Feasibility of a Novel Bipolar Radiofrequency Ablation Knife in Esophageal Endoscopic Submucosal Dissection

Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Bayl…

Esophageal NeoplasmEsophageal PolypEndoscopic Submucosal Dissection+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Baylor College of MedicineNCT06476678

Phase 3

Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma

This clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to standard-course radiation therapy over …

Recurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesResectable Soft Tissue Sarcoma of the Trunk and ExtremitiesSoft Tissue Sarcoma of the Trunk and Extremities+2 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AIMS Medical Outcomes Study

This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical …

Mental Health IssuePTSDPain+2 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Advanced Integrative Medical Science InstituteNCT04512755

Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors

This is an investigation of possible relationships between daily physical activity (PA) and different measurements of fatigue in cancer survivors participating…

Cancer Remission

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT05073848

Phase 2

An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease

The specific objective of this study is to perform a small, open-label study to assess the safety and efficacy of intralesional, subcutaneous injection of STS …

Systemic Sclerosis (SSc)DermatomyositisMixed Connective Tissue Disease (MCTD)+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Robyn T. Domsic, MD, MPHNCT06672822

Phase 1

Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)

The purpose of this Phase 1, first in human open-label study is to assess the safety and tolerability of TRX-103 in patients with hematological malignancies un…

Hematologic MalignancyGvHDGVHD,Acute+8 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Tr1X, Inc.NCT06462365

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and op…

SarcomaChildhood Sarcoma of Soft Tissue

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT07402577

Phase 1

A Randomized Phase I/II Study of Talazoparib or Temozolomide in Combination With Onivyde in Children With Recurrent Solid Malignancies and Ewing Sarcoma

The phase I portion of this study is designed for children or adolescents and young adults (AYA) with a diagnosis of a solid tumor that has recurred (come back…

Recurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.